FDA cannot keep track of medical devices and their manufacturers
This article was originally published in Clinica
The US General Accounting Office (GAO) has identified "several weaknesses" in the FDA's regulation of medical device tracking which it says threatens the agency's ability to adequately protect the public.
You may also be interested in...
As the coronavirus continues to spread, one of the big four global vaccines companies has committed itself to the fight.
Sweden’s mid-sized pharmaceutical company, Swedish Orphan Biovitrum, has expanded into hematology and strengthened its immunology business, growing its top and bottom lines in 2019.